Takeda Pharmaceutical's revenue in FY 2016, by segment
The statistic shows the revenue of Takeda Pharmaceutical Co., Ltd. in fiscal year 2016, broken down by segment. That year, the prescription drug segment of the Japanese pharmaceutical company Takeda generated a revenue of approximately 1.57 trillion Japanese yen, whereas the consumer healthcare segment's revenue amounted to around 82.57 billion yen. With changes in the company structure in April 2017 the company has reconsidered its segment structure and concluded that Takeda comprises one operating segment: pharmaceutical products. Hence, from fiscal year 2017 onwards the revenue breakdown by segment will no longer be reported.